While measures implemented by CMS in 2017 stabilized the individual marketplace and improved performance of health insurance exchanges, those without federal subsidies have limited coverage options, according to the reports.
Three reports released by CMS provide an update on the current status of the federal and state-based health insurance exchanges and the individual health insurance markets. While measures implemented in 2017 stabilized the individual marketplace and improved performance of the exchanges, those without subsidies have limited coverage options, according to the reports.
The 3 reports are:
The reports focused on the following aspects of the exchanges:
The individual health insurance marketplace saw a decline in 23 states between 2015 and 2016, particularly among the unsubsidized individuals, with double-digit declines in 10 states. A big cause for concern is the disparity in reduction between subsidized versus unsubsidized enrollment seen for the 2017 plan year: a 3% drop versus a 20% drop, respectively. This drop coincided with a 21% growth in average monthly premiums.
In response to this troubling drop in the individual exchanges, CMS utilized and expanded the role of private brokers and insurance agents who were documented to have assisted with 3,660,668 health plan enrollments and 42% of 2018 plan open enrollments on the federal exchanges. This was a big success compared with navigators, who enrolled less than 1% of total enrollees.
Another significant change was enhancement of the risk pool—CMS forced people to verify their qualification for Special Enrollment Periods, or SEPs, which caused a 56% decline in SEPs granted for the 2017 plan year.
The reports claim that enhancements to the federal exchange platforms helped maintain a steady effectuated enrollment rate for subsidized individuals who were moving into the 2018 plan year—a 3% growth was noted in effectuated enrollment by February 2018, compared with the same time last year. Enrollees on the exchanges rely on federal subsidies, the report shows; 87% enrolled in the 2018 plan year are dependent on Advance Premium Tax Credits—a 3% increase over the prior year.
Rising premiums on exchange plans exerted significant stress on the overall system and pushed federal spending on premium subsidies. Monthly premiums rose by 27% in 2018 following a 21% increase in 2017. Subsequently, the average federal premium subsidy rose by 39% in 2018, which is projected to increase federal spending on premium subsidies by $17 billion in this year.
The Exchange Trend Report, which delved into affordability, financial assistance, and plan choice for consumers on the Exchanges, found that lack of affordability remains a driving force that influences currently uninsured consumers’ decision to buy their healthcare coverage on the exchange through the federal platform.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More